02.09.15
Maple Grove, Minn.-based NxThera Inc., which makes technology for the treatment of endourology conditions, has hired Maximillian D. Fiore as its chief development & operations officer. In this new role, Fiore will lead the company’s development and operations organizations as NxThera begins to scale production and expand commercial availability of its Rezum system to treat benign prostatic hyperplasia (BPH).
“Max has led the development and scaled production of numerous commercially successful products in both large and early-stage companies,” said President and CEO Bob Paulson. “Max adds significant strategic and operating breadth and depth to our leadership team as we begin to expand commercial availability of our Rezum system internationally and prepare for U.S. launch following U.S. Food and Drug Administration clearance.”
Fiore brings more than 30 years of experience in the medical device industry in a variety of product development, operations and R&D leadership roles. He most recently served as the senior vice president and chief technology officer for American Medical Systems (AMS) from 2009-2013. Prior to AMS, Max held a variety of R&D and operations leadership roles at OmniSonics, Smith & Nephew, Aradigm, LifeScan, Abbott Diagnostics, Abbott Hospital Products, and Lawrence Livermore National Laboratory. Max earned his B.S.E.E. and B.S.Eng. in electrical and electronics engineering and biomedical engineering from Northwestern University, and his M.S.E.E. in biomedical instrumentation from the University of Wisconsin-Madison.
NxThera is developing its Convective water vapor energy (Wave) technology platform to treat a variety of endourology conditions beginning with BPH, and including prostate cancer and kidney cancer.
“Max has led the development and scaled production of numerous commercially successful products in both large and early-stage companies,” said President and CEO Bob Paulson. “Max adds significant strategic and operating breadth and depth to our leadership team as we begin to expand commercial availability of our Rezum system internationally and prepare for U.S. launch following U.S. Food and Drug Administration clearance.”
Fiore brings more than 30 years of experience in the medical device industry in a variety of product development, operations and R&D leadership roles. He most recently served as the senior vice president and chief technology officer for American Medical Systems (AMS) from 2009-2013. Prior to AMS, Max held a variety of R&D and operations leadership roles at OmniSonics, Smith & Nephew, Aradigm, LifeScan, Abbott Diagnostics, Abbott Hospital Products, and Lawrence Livermore National Laboratory. Max earned his B.S.E.E. and B.S.Eng. in electrical and electronics engineering and biomedical engineering from Northwestern University, and his M.S.E.E. in biomedical instrumentation from the University of Wisconsin-Madison.
NxThera is developing its Convective water vapor energy (Wave) technology platform to treat a variety of endourology conditions beginning with BPH, and including prostate cancer and kidney cancer.